Omron 2016 Annual Report Download - page 45

Download and view the complete annual report

Please find page 45 of the 2016 Omron annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 102

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102

During the 1990s, the Matsusaka Factory produced more than
1 million blood pressure monitors annually. As production
shifted to China and Vietnam, the rate of production fell to
260,000 units. More recently, however, an increase in inbound
tourist demand in Japan and a greater focus on quality both in
Japan and throughout Asia has given rise to greater demand for
products labeled
Made in Japan.
Such products include blood
pressure monitors and other health and medical equipment
where demand is high for items made in Japan.
 To respond to this dramatic shift in demand, the Matsusaka
Factory has built a production system that delivers stable output.
This system features new technologies to reduce assembly
time, a higher ratio of domestic component procurement, and
other means to maintain a competitive cost structure. The
factory ramped up production during fiscal 2014, forecasting
total production of 1.7 million blood pressure monitors in fiscal
2016. This increase in production has much to do with this
year
s adoption of the world
s first automated assembly line for
blood pressure monitors. By automating processes that used to
require several people to accomplish, the factory has more than
doubled per-person productivity. In addition to adding more
manufacturing technology to increase production in Japan, the
Matsusaka Factory is training technical staff who can supervise
production overseas. These individuals will introduce
technologies proven at Matsusaka at overseas production
centers, which will lead to further productivity gains for the
Healthcare Business.
Emphasis on production efficiency for a
cost structure competitive with overseas
manufacturers. Freely changing the number of
workers and processes allows the factory to handle
changes in product type and production numbers.
Advances in technology led to the world
s first
automated assembly line for blood pressure
monitors. Robots replace human workers to deliver
greater productivity and quality in component,
module, and finished product assembly.
The Return of
Made in Matsusaka
Blood Pressure Monitors
Manual Assembly
Automated Assembly
Blood Pressure Monitor Production Line
Fiscal 2016
plan
1,700
thousand
units
Fiscal 2013
260
thousand
units
43
Integrated Report 2016
Where We
re HeadedAbout Omron Corporate Value Initiatives Corporate Value Foundation Financial SectionCorporate Value Initiatives